BioScale Raises $18.8M; Targets $38.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said in a regulatory document that it has raised $18.8 million of a targeted $38.3 million financing round.

The Lexington, Mass.-based firm disclosed the raise in a document filed on Monday with the US Securities and Exchange Commission, saying the securities offered were in the form of equity. It did not disclose the names of the investors but said 69 investors have invested in the offering. It did not say how proceeds from the raise would be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.